Grant Detail
The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
Discovery of highly toxic synuclein sequence variants
1 April 2005 - 31 March 2007
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 172,694
This project seeks to screen a library of alpha-synuclein mutants, created via error-prone PCR, in a neuroblastoma cell-line model system of Parkinson's disease. Alpha-Synuclein cDNA sequence variants will be individually purified (high throughput format) and transfected into cells in individual wells of multiwell plates. A medium-throughput screen (ca. 104 sequences) will then identify those mutants which produce a highly neurotoxic phenotype (e.g., oxidative stress, apoptosis), relative to wild type alpha-synuclein. Subsequent in vitro aggregation studies of these highly toxic mutants will enable us to confirm or rule out various oligomeric forms (protofibril, pore structure, and fibril) of synuclein as cytotoxic, aiding our understanding of the role of aggregation in PD, validating drug targets, and providing direction for future research. Additionally, the multiwell plate based model system and assays of PD will be directly useful for screening compound libraries for new PD drug candidates. Finally, the extremely toxic sequence variants will be valuable tools in of themselves that may make more apparent the cytotoxic pathways stimulated by wild type alpha-synuclein and will make possible more robust and phenotypically correct transgenic animal models of PD.
2 Resulting Publications
-
1.
2011Katherina Vamvaca; Peter T Lansbury; Leonidas Stefanis
Journal of neurochemistry 2011;119(2):389-97. -
2.
2007Michael J Volles; Peter T Lansbury
Journal of molecular biology 2007;366(5):1510-22.
Scientific Context
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Related Grants
-
1.
Rogers, Jack T
RNA Targeted Screens of the Prion 5'UTR
30 September 2008 - 31 August 2010
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 269,917
-
2.
Lansbury, Peter T
Familial Parkinson's Disease: Clues to Pathogenesis
1 August 2000 - 31 August 2010
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 16,380,885
-
3.
SELKOE, DENNIS J
Alpha-Synuclein, PUFA and Membrane Vesicles in Health and Parkinson's Disease
15 January 2006 - 31 December 2010
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 1,547,257
Related Publications
-
1.
2000N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(16):6048-54. -
2.
2003Makoto Hashimoto; Takato Takenouchi; Edward Rockenstein; Eliezer Masliah
Journal of neurochemistry 2003;85(6):1468-79. -
3.
2005Yutaka Machida; Tomoki Chiba; Atsushi Takayanagi; Yoshikazu Tanaka; Masato Asanuma; Norio Ogawa; Akihiko Koyama; Takeshi Iwatsubo; Shosuke Ito; Poul Hening Jansen; et al.
Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Biochemical and biophysical research communications 2005;332(1):233-40.


Appears in this Publication








